A team from UT Southwestern (UTSW) has found that a significant number of breast cancer patients have higher levels of the ZMYND8 gene, making it a potential target for immunotherapies and precision...
Potential jurors may not be strongly opposed to providers’ acceptance of artificial intelligence medical recommendations, indicating that clinicians may be less liable for medical malpractice...
Researchers from the Johns Hopkins departments of oncology and pathology, the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University (JHU) School of Medicine, and 18 other organizations...
Genetic markers related to mineral bone accrual could help providers identify younger patients at risk of fractures in later life, according to a study published in Genome Biology.
Osteoporosis is a...
A new tool that focuses on RNA could accelerate the development of precision medicine treatments for incurable diseases, including a type of metastatic breast cancer, according to a study published in...
Researchers at the Perelman School of Medicine at the University of Pennsylvania have received a $4.8 million grant from the National Institute on Aging (NIA) to study the genetics of Alzheimer’s...
NIH’s All of Us precision medicine research program is beginning to return genetic results to participants, with individuals now able to receive information about their genetic ancestry and...
Researchers from Penn Medicine have discovered a new biomarker that identifies which patients with aggressive lymphoma won’t respond to a precision medicine treatment called ibrutinib.
The...
Children’s Hospital of Pennsylvania (CHOP) and Gustave Roussy, a cancer research organization based in France, have received a $1.3 million grant from neuroblastoma clinical research charities to...
While the promises of precision medicine in healthcare are seemingly boundless, the industry has had to overcome several challenges to integrating these approaches with everyday clinical care.
From...
A precision medicine treatment that involves correcting an underlying genetic mutation led to the reversal of a case of type 1 diabetes, according to a study published in the New England Journal of...
Broad-based genetic testing could identify inherited genetic mutations and accelerate precision medicine therapies for patients with cancer, according to a study published in JAMA Oncology.
Hereditary...
A deep learning algorithm was able to accurately analyze tumor data and recommend the best possible treatments for patients, potentially accelerating cancer precision medicine, according to a study...
After analyzing the genomic data of men of different races, researchers believe that a combination of socioeconomic and biological factors may contribute to racial disparities in prostate cancer...
Right now, there are more than 46 million adults age 65 and older living in the US. By 2050, that number is expected to grow to almost 90 million.
This means that in just ten years, one in five Americans is projected to be 65 or...
UC San Francisco (UCSF) is using a $1 million grant to build a first-of-its-kind diagnostic center that will aim to use precision medicine methods to find targeted therapies for type 1 diabetes.
The...
Precision medicine has emerged in recent years as a potential way to deliver personalized, comprehensive care to patients with a wide range of diseases.
In just the last few months, researchers have...
Patients with advanced cancer who received precision medicine treatments were more likely to survive or have longer periods without their disease progressing than those who received standard therapies,...
A new tool designed to collect eye fluid samples could help providers develop specific treatment plans for patients, facilitating precision medicine for eye diseases.
Researchers from the University...
The University of Chicago Pediatric Cancer Data Commons (PCDC) is participating in new collaborative effort to leverage big data to advance pediatric cancer precision medicine.
The global initiative,...
